Publication | Closed Access

Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial

VaccinationVaccine SafetyPulmonary TuberculosisTuberculosis PreventionImmunologySouth AfricaVaccine TrialTuberculosisVaccine EfficacyBcg-vaccinated Healthy AdultsPreventive TreatmentImmunotherapyMedicinePlacebo-controlled Phase 1